PureCycle Technologies filings document its recycled polypropylene business, governance, and capital structure. Recent 8-K reports disclose operating results, investor presentations, Ironton production updates, PureFive resin commercialization activity, and material agreements affecting the company’s outstanding warrants.
Proxy and shareholder-vote filings cover director elections, auditor ratification, executive compensation votes, and consent solicitations for warrant holders. The filing record also describes common stock, public and private warrants, Series A warrants, warrant agreement amendments, redemption mechanics, expiration terms, and other capital-structure matters tied to the company’s securities.
PureCycle Technologies (PCT) director Siri Jirapongphan filed a Form 3 initial beneficial ownership statement. The filing lists Series B Convertible Perpetual Preferred Stock with a $14.02 conversion price and notes the security is perpetual with no expiration.
The explanation states Dr. Jirapongphan purchased 300 shares of Series B at $1,000 per share for an aggregate $300,000. The Series B is convertible into common stock at a rate equal to the sum of $1,000 plus in‑kind and accrued dividends divided by the conversion price. The table reflects a date exercisable of 06/20/2025 and direct ownership.
PureCycle Technologies (PCT) filed its Q3 2025 10‑Q, reporting first product revenue and stronger liquidity. Revenue reached $2.43 million in the quarter and $5.66 million year‑to‑date as the company began selling output from its recycling operations. The quarterly net loss was $28.37 million, an improvement from a $90.64 million loss a year ago, aided by a favorable $23.75 million change in warrant fair value and higher interest income.
Cash and cash equivalents were $234.36 million as of September 30, 2025, up from $15.68 million at year‑end, largely from financing activities including the June issuance of $300.0 million of Series B Convertible Perpetual Preferred Stock. Total assets were $989.12 million and total liabilities were $621.60 million. The company reported mezzanine equity of $299.30 million related to the Series B and stockholders’ equity of $68.22 million. Management stated that prior substantial doubt about going concern is no longer present based on proceeds from the Series B raise. Common shares outstanding were approximately 180.20 million as of November 4, 2025.
PureCycle Technologies (PCT) entered a Tenth Amendment to its Revolving Credit Agreement, extending the maturity of its $200 million revolving credit facility from September 30, 2026 to September 30, 2027. The amendment was executed on November 4, 2025 with existing lenders affiliated with Sylebra Capital, who are greater than 5% beneficial owners, and Madison Pacific Trust as administrative and security agent.
The filing also notes a press release announcing third-quarter 2025 results and an investor presentation, both dated November 6, 2025, furnished as exhibits. The maturity extension adds an additional year to the company’s committed liquidity framework without changing the disclosed facility size.
PureCycle Technologies (PCT) reported insider activity tied to a board change. Director Jeffrey Richard Fieler resigned effective October 30, 2025. In connection with his resignation, the Board accelerated 50% of his May 2025 annual grant, and the remaining 9,675 shares were forfeited (coded “D” at $0). He also surrendered 2,902 shares (code “F”) at $11.34 to cover taxes on a vesting event under the 2021 Equity and Incentive Plan. Following these transactions, he directly beneficially owned 1,970,526 shares.
PureCycle Technologies (PCT) announced board changes. The Board appointed Dr. Siri Jirapongphan as a director effective October 28, 2025, with the Board anticipating his service on the Operational Excellence Committee. The Board determined he qualifies as an independent director under Nasdaq rules.
Dr. Jirapongphan will receive a prorated initial non-employee director award of restricted stock units with a grant date value of $62,500 for the six-month period until the 2026 Annual Meeting under the 2021 Equity and Incentive Compensation Plan. He previously purchased 300 shares of the Company’s Series B Convertible Perpetual Preferred Stock at $1,000 per share (aggregate $300,000) in a private placement that closed on June 20, 2025. He will also enter into the Company’s standard-form indemnification agreement.
On October 30, 2025, Jeffrey R. Fieler resigned from the Board, effective immediately. His resignation was not due to any disagreement, and his 2025 non-employee director grant will vest immediately, pro-rated for six months of service.
PureCycle Technologies, Inc. filed a current report to furnish information under Regulation FD about its participation in the TPO 2025 Global Automotive Conference on October 1, 2025. The company attached as Exhibit 99.1 a presentation titled “Class A, Painted Automotive Plastics Parts from 100% Post-Consumer Recycled PP Presentation,” highlighting its work with recycled polypropylene in automotive applications. The information in Item 7.01 is expressly furnished, not filed, meaning it is not automatically subject to certain liability provisions or incorporated into other securities law filings unless specifically referenced. The report also notes that the presentation may contain forward-looking statements about the company’s technology and prospects, which are subject to risks and uncertainties that could cause actual results to differ materially.
PureCycle Technologies insider reported a tax-related share surrender and existing indirect ownership via a family trust. Director and officer Brad S. Kalter disposed of 2,830 shares of Common Stock on 09/23/2025 at $13.90 per share to cover tax withholding related to the vesting of an equity grant. After the transaction, Mr. Kalter directly beneficially owns 156,849 shares. The filing also discloses an indirect holding of 120,000 shares held by the Brad S. Kalter and Julie F. Kalter Revocable Trust. The Form 4 was signed by an attorney-in-fact on 09/24/2025.